These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

780 related articles for article (PubMed ID: 19097840)

  • 1. Distribution of capsular serotypes and macrolide resistance mechanisms among macrolide-resistant Streptococcus pneumoniae isolates in Korea.
    Bae S; Lee K
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):213-6. PubMed ID: 19097840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterisation of Canadian paediatric multidrug-resistant Streptococcus pneumoniae from 1998-2004.
    Zhanel GG; Wang X; Nichol K; Nikulin A; Wierzbowski AK; Mulvey M; Hoban DJ
    Int J Antimicrob Agents; 2006 Nov; 28(5):465-71. PubMed ID: 17049211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain.
    Calatayud L; Ardanuy C; Cercenado E; Fenoll A; Bouza E; Pallares R; Martín R; Liñares J
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3240-6. PubMed ID: 17606677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ; Klugman KP; Pichichero M
    Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT Year 5 (2003-2004).
    Farrell DJ; Couturier C; Hryniewicz W
    Int J Antimicrob Agents; 2008 Mar; 31(3):245-9. PubMed ID: 18178388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
    Farrell DJ; Jenkins SG
    J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypes of macrolide-resistant pneumococci from children in southwestern Japan: raised incidence of strains that have both erm(B) and mef(A) with serotype 6B clones.
    Ikenaga M; Kosowska-Shick K; Gotoh K; Hidaka H; Koga H; Masunaga K; Nagai K; Tsumura N; Appelbaum PC; Matsuishi T
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):16-22. PubMed ID: 18068325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution and molecular characterization of macrolide-resistant Streptococcus pneumoniae in Canada between 1998 and 2008.
    Wierzbowski AK; Karlowsky JA; Adam HJ; Nichol KA; Hoban DJ; Zhanel GG;
    J Antimicrob Chemother; 2014 Jan; 69(1):59-66. PubMed ID: 23970485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic susceptibility according to genotype of penicillin-binding protein and macrolide resistance genes, and serotype of Streptococcus pneumoniae isolates from community-acquired pneumonia in children.
    Chiba N; Kobayashi R; Hasegawa K; Morozumi M; Nakayama E; Tajima T; Iwata S; Ubukata K;
    J Antimicrob Chemother; 2005 Oct; 56(4):756-60. PubMed ID: 16131518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolide resistance determinants in erythromycin-resistant Streptococcus pneumoniae in Turkey.
    Gulay Z; Ozbek OA; Bicmen M; Gur D
    Jpn J Infect Dis; 2008 Nov; 61(6):490-3. PubMed ID: 19050364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of macrolide resistance in Streptococcus pneumoniae clinical isolates in the prevaccine era.
    Daikos GL; Koutsolioutsou A; Tsiodras S; Theodoridou M; Koutouzis EI; Charissiadou A; Pangalis A; Michos AG; Chaidopoulou F; Braoudaki M; Syriopoulou VP
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):393-8. PubMed ID: 18077121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany.
    Bley C; van der Linden M; Reinert RR
    Int J Antimicrob Agents; 2011 May; 37(5):425-31. PubMed ID: 21419605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis and clonal nature of increasing pneumococcal macrolide resistance in South Africa, 2000-2005.
    Wolter N; von Gottberg A; du Plessis M; de Gouveia L; Klugman KP;
    Int J Antimicrob Agents; 2008 Jul; 32(1):62-7. PubMed ID: 18339522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP).
    Song JH; Chang HH; Suh JY; Ko KS; Jung SI; Oh WS; Peck KR; Lee NY; Yang Y; Chongthaleong A; Aswapokee N; Chiu CH; Lalitha MK; Perera J; Yee TT; Kumararasinghe G; Jamal F; Kamarulazaman A; Parasakthi N; Van PH; So T; Ng TK;
    J Antimicrob Chemother; 2004 Mar; 53(3):457-63. PubMed ID: 14963068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of serotype and genotype in Streptococcus pneumoniae isolates from a Korean hospital in 2007.
    Song JH; Baek JY; Cheong HS; Chung DR; Peck KR; Ko KS
    Diagn Microbiol Infect Dis; 2009 Mar; 63(3):271-8. PubMed ID: 19179034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
    Richter SS; Heilmann KP; Dohrn CL; Riahi F; Beekmann SE; Doern GV
    Clin Infect Dis; 2009 Feb; 48(3):e23-33. PubMed ID: 19115971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotypes and serotype distribution of macrolide resistant invasive and non-invasive Streptococcus pneumoniae isolates from Lebanon.
    Taha N; Araj GF; Wakim RH; Kanj SS; Kanafani ZA; Sabra A; Khairallah MT; Nassar FJ; Shehab M; Baroud M; Dbaibo G; Matar GM
    Ann Clin Microbiol Antimicrob; 2012 Jan; 11():2. PubMed ID: 22248318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of macrolide-non-susceptible Streptococcus pneumoniae colonising children attending day-care centres in Athens, Greece during 2000 and 2003.
    Souli M; Volonakis K; Kapaskelis A; Galani I; Grammelis V; Vorou R; Tsivra M; Chryssouli Z; Katsala D; Giamarellou H
    Clin Microbiol Infect; 2007 Jan; 13(1):70-7. PubMed ID: 17184290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.